CareDx Appoints Bryan Riggsbee to Its Board of Directors [Yahoo! Finance]
CareDx, Inc. (CDNA)
Last caredx, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.caredxinc.com
Company Research
Source: Yahoo! Finance
focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers — today announced that Bryan Riggsbee joins CareDx's Board of Directors, effective March 11, 2024. "We're pleased to welcome Bryan to our Board," said Michael Goldberg, CareDx Board Chairperson. "His financial expertise, operating background and deep understanding of revenue cycle management in molecular diagnostics will allow him to make meaningful contributions to our Board." Riggsbee previously served as Chief Financial Officer at Myriad Genetics, where he made substantial contributions to the company's growth strategy and business transformation. With a decade-long tenure at Laboratory Corporation of America (LabCorp), Riggsbee has demonstrated proven financial acumen. His background also includes notable finance roles at General Electric Company. He began his career in the audit division of KPMG and is a Certified Pu
Show less
Read more
Impact Snapshot
Event Time:
CDNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CDNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CDNA alerts
High impacting CareDx, Inc. news events
Weekly update
A roundup of the hottest topics
CDNA
News
- Cytonus Therapeutics Expands C-suite as it Transitions to a Clinical Stage Company [Yahoo! Finance]Yahoo! Finance
- CareDx Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]Yahoo! Finance
- CareDx Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)Business Wire
- CareDx (CDNA) Moves 5.5% Higher: Will This Strength Last? [Yahoo! Finance]Yahoo! Finance
- CareDx, Inc (NASDAQ: CDNA) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $15.00 price target on the stock.MarketBeat
CDNA
Earnings
- 2/28/24 - Beat
CDNA
Sec Filings
- 4/25/24 - Form S-8
- 4/25/24 - Form 3
- 4/22/24 - Form 4
- CDNA's page on the SEC website